Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

NCT00941603 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

619

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia
Mixed Hyperlipidemia

Interventions

DRUG: SCH 900271 15mg
DRUG: SCH 900271
DRUG: SCH 900271
DRUG: SCH 900271
DRUG: SCH 900271
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC